|
YTHDC1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.449800E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.057800E-01 |
| Normal-vs-Stage2 |
1.892770E-01 |
| Normal-vs-Stage3 |
1.382960E-04 |
| Normal-vs-Stage4 |
7.71489999995545E-07 |
| Stage1-vs-Stage2 |
1.631550E-01 |
| Stage1-vs-Stage3 |
1.55291999999196E-05 |
| Stage1-vs-Stage4 |
4.72509997795356E-09 |
| Stage2-vs-Stage3 |
1.387200E-01 |
| Stage2-vs-Stage4 |
2.529700E-02 |
| Stage3-vs-Stage4 |
2.382000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.074100E-02 |
| Normal-vs-AfricanAmerican |
3.979000E-01 |
| Normal-vs-Asian |
4.809600E-01 |
| Caucasian-vs-AfricanAmerican |
3.283000E-01 |
| Caucasian-vs-Asian |
1.381030E-01 |
| AfricanAmerican-vs-Asian |
3.620200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.897000E-03 |
| Normal-vs-Female |
3.023600E-01 |
| Male-vs-Female |
2.912100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.380010E-01 |
| Normal-vs-Age(41-60Yrs) |
1.765440E-01 |
| Normal-vs-Age(61-80Yrs) |
7.498300E-03 |
| Normal-vs-Age(81-100Yrs) |
2.621700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.166400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.300200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.230400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.923900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.513030E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.834000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.304400E-03 |
| Normal-vs-Grade 2 |
9.528200E-01 |
| Normal-vs-Grade 3 |
9.782200E-04 |
| Normal-vs-Grade 4 |
2.59709997951774E-09 |
| Grade 1-vs-Grade 2 |
2.420100E-03 |
| Grade 1-vs-Grade 3 |
3.08740000010133E-07 |
| Grade 1-vs-Grade 4 |
1.50189860548267E-11 |
| Grade 2-vs-Grade 3 |
1.94183999999709E-05 |
| Grade 2-vs-Grade 4 |
2.65598654181076E-12 |
| Grade 3-vs-Grade 4 |
2.790700E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.672410E-01 |
| Normal-vs-ccB subtype |
5.91099999946998E-07 |
| ccA subtype-vs-ccB subtype |
1.11022302462516E-15 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.268100E-02 |
| Normal-vs-N1 |
2.484000E-03 |
| N0-vs-N1 |
7.180200E-02 |
|
|
